In response to "health screening on aconcagua"

Wilderness and Environmental Medicine

Volumn 20, Issue 4, 2009, Pages 393-394

  Lazio, Matthew P ^a   Van Roo, Jon D ^a   Malik, Sanjeev ^a   Courtney, D Mark ^a   Pesce, Carlos ^a  

^a Buenos Aires ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACCLIMATIZATION; ALTITUDE; ALTITUDE DISEASE; BLOOD PRESSURE; HEALTH STATUS; HUMAN; HYPERTENSION; MOUNTAINEERING; NOTE; PATHOLOGY; PHYSIOLOGY;

ACCLIMATIZATION; ALTITUDE; ALTITUDE SICKNESS; BLOOD PRESSURE; HEALTH STATUS; HUMANS; HYPERTENSION; MOUNTAINEERING;

EID: 75449114860     PISSN: 10806032     EISSN: None     Source Type: Journal    
DOI: 10.1580/1080-6032-020.004.0393     Document Type: Letter

References (4)

1. Windsor JS, Currie RJ, Grocott M, Chioconi R, Hillebrandt D. Health screening on Aconcagua. Wild Envir Med. 2009; 20:90-104.
2. Williams B, Poulter NR, Brown MJ, et al.. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ. 2004;328:634-640. (Pubitemid 38340037)
3. Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, Yeh C. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol. 2003;4:45-52.
4. Pesce C, Leal C, Pinto H, et al.. Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m). High Alt Med Biol. 2005;6:158-166.